Advertisement
Screener

VAXCYTE, INC. (PCVX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

VAXCYTE, INC. Cash Flow Breakdown

Cash flow breakdown shows where VAXCYTE, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $655.58M went out.
  • Fiscal year ended 2025-12-31: from investing, $437.35M came in.
  • Fiscal year ended 2025-12-31: from financing, $2.01M came in.
  • Fiscal year ended 2025-12-31: change in cash, $213.77M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$655.58M$437.35M-$10.99M$13.01M-$213.77M
2024-12-31-$452.63M-$2.01B-$14.29M$195.94M$2.27B*-$9.36M
2023-12-31-$296.79M-$773.31M-$3.88M$90.74M$552.95M*-$436.97M
2022-12-31-$170.60M$74.58M-$861.00K$97.30M$765.11M*$765.67M
2021-12-31-$121.39M-$212.31M$13.90M$3.90M*-$316.34M
2020-12-31-$46.63M-$1.10M$0.00$374.87M*$327.22M
2019-12-31-$47.15M-$1.20M$322.00K$41.24M*-$7.11M
2018-12-31-$30.47M-$1.77M$5.00K$62.19M*$29.95M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$232.47M*$147.72M*-$2.06M*$7.76M*
2026-03-31-$280.63M-$233.41M-$9.29M$9.03M$601.85M*$86.88M
2025-12-31-$224.83M*$115.13M*-$1.01M*$3.42M*
2025-09-30-$143.31M*$121.17M*-$3.98M*$306.00K*
2025-06-30-$121.17M*$77.74M*-$717.00K*$3.23M*
2025-03-31-$166.27M$123.32M-$5.29M$6.05M-$41.03M
2024-12-31-$111.40M*-$557.17M*-$1.08M*$5.98M*
2024-09-30-$60.71M*-$917.02M*-$9.34M*$89.46M*$1.43B*
2024-06-30-$121.39M*-$80.41M*-$565.00K*$106.51M*$4.42M*
2024-03-31-$159.12M-$451.07M-$3.31M$5.02M$816.48M*$214.06M
2023-12-31-$128.81M*-$13.93M*-$46.00K*$2.78M*
2023-09-30-$57.55M*$22.28M*$49.00M*
2023-06-30-$62.74M*-$333.56M*$0.00*$546.97M*
2023-03-31-$47.69M-$448.10M$41.79M-$454.21M
2022-12-31-$65.22M*-$35.95M*$2.06M*$654.57M*
2022-09-30-$38.55M*$34.71M*$43.12M*$896.00K*
2022-06-30-$39.13M*$26.16M*$49.00M*$876.00K*
2022-03-31-$27.70M$49.67M$3.12M$107.90M*$132.76M
2021-12-31-$51.09M*$82.00K*$6.79M*$1.97M*
2021-09-30-$28.41M*-$18.47M*$7.11M*
2021-06-30-$28.68M*-$20.53M*$466.00K*
2021-03-31-$13.21M-$173.39M$487.00K-$186.39M
2020-12-31-$10.77M*-$722.00K*$181.00K*
2020-09-30-$13.05M*$21.00K*$108.00K*
2020-06-30-$9.17M*-$55.00K*$297.00K*$264.19M*
2020-03-31-$13.63M-$349.00K$49.00K$109.75M*$95.81M
2019-12-31-$14.41M*-$953.00K*$7.00K*$41.34M*
2019-09-30-$9.46M*-$60.00K*$313.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
CRISPR Therapeutics AG (CRSP)$5.390B-11.68